Merck (NYSE:MRK) announced on Thursday that its Phase 3 KEYNOTE-B96 trial for its anti-PD-1 therapy Keytruda reached the ...

Corcept Therapeutics CORT announced that it has submitted a marketing authorization application (MAA) seeking approval for ...

Ovarian cancer is frequently referred to as a “silent killer,” because it develops secretly and generally isn’t discovered until late. Some women don’t recognize what are in fact the daily ...

Several factors make ovarian cancer particularly challenging to treat. This is largely because the cancer often spreads at a ...

FARGO, N.D. (Valley News Live) - A 20-year-old college student from the Fargo-Moorhead area is turning her unexpected cancer ...

Ovarian cancer is an abnormal growth of cells or tumors in the ovaries. Some forms of ovarian cancer are more aggressive than ...

German biotech firm Tubulis said on Wednesday it had raised 308 million euros ($358 million) in its biggest financing round ...

The new test, called the risk of ovarian cancer algorithm (Roca), calculates a woman’s individual risk based on factors such ...

Preventing relapse of advanced ovarian cancer with PARP inhibitors is now an established strategy. As data from pivotal ...

Beyond medical interventions, diet and lifestyle significantly enhance ovarian cancer recovery and quality of life. A balanced diet, rich in whole foo ...

Ovarian cancer is known for its aggressive spread, often targeting fatty tissues in the abdomen. Now, a study published in ...

One study from Canada concluded in 2023 that hairdressing and accountancy, among other jobs, correlated with a higher risk of ovarian cancer.